Related Experiment Video

Updated: May 19, 2026

Silencing of BRCA2 to Identify Novel BRCA2-regulated Biological Functions in Cultured Human Cells
09:24

Silencing of BRCA2 to Identify Novel BRCA2-regulated Biological Functions in Cultured Human Cells

Published on: August 12, 2015

BH3-only protein silencing contributes to acquired resistance to PLX4720 in human melanoma

Y Shao1, A E Aplin

  • 1Department of Cancer Biology and Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA 19107, USA.

Cell Death and Differentiation
|August 4, 2012
PubMed

Insights

Melanoma patients develop resistance to RAF inhibitors like vemurafenib. This resistance involves ERK1/2 reactivation and silenced pro-apoptotic proteins. Combining HDAC and MEK inhibitors may overcome this resistance.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • BRAF mutations drive 50% of melanomas and are targeted by RAF inhibitors like vemurafenib.
  • Vemurafenib shows high initial response rates but acquired resistance limits long-term efficacy.
  • Understanding resistance mechanisms is crucial for improving melanoma treatment outcomes.

Purpose of the Study:

  • To investigate the molecular mechanisms underlying acquired resistance to RAF inhibitors in BRAF-mutant melanoma.
  • To identify potential therapeutic strategies to overcome vemurafenib resistance.

Main Methods:

  • Developed vemurafenib-resistant melanoma cell lines via continuous drug exposure.
  • Analyzed signaling pathway reactivation (ERK1/2) and cell-cycle progression.
  • Assessed changes in pro-apoptotic BH3-only proteins (Bim-EL, Bmf).
  • Evaluated the efficacy of MEK inhibitors and histone deacetylase (HDAC) inhibitors in resistant cells.

Main Results:

  • Resistant cells exhibited partial ERK1/2 reactivation, G1/S cell-cycle recovery, and suppressed Bim-EL/Bmf.
  • MEK inhibitors blocked cell-cycle progression but did not restore apoptosis or BH3-only proteins.
  • HDAC inhibitors de-repressed Bim-EL and enhanced cell death in combination with RAF or MEK inhibitors.

Conclusions:

  • Acquired resistance to vemurafenib involves both ERK1/2 reactivation and ERK1/2-independent silencing of BH3-only proteins.
  • Combined therapy with HDAC inhibitors and MEK inhibitors shows promise for overcoming vemurafenib resistance in melanoma.

More Related Videos

Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down08:59

Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down

Published on: December 11, 2017

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells07:23

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells

Published on: May 30, 2025

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Gene Regulation in Microbial Communities: Quorum Sensing01:28

Gene Regulation in Microbial Communities: Quorum Sensing

Quorum sensing is a mechanism of bacterial communication that enables coordinated gene expression in response to changes in population density. This facilitates collective behaviors that enhance survival, resource acquisition, and ecological adaptation. This process relies on small signaling molecules called autoinducers that accumulate as bacterial populations grow. When a critical threshold concentration of autoinducers is reached, bacterial cells collectively modify gene expression,...